Impact GLP-1 Agonists Following Bariatric — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact GLP-1 Agonists Following Bariatric — Stella

Recruiting

Back to Morbid Obesity trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Missouri Hospital, Columbia, Missouri

Key details

Phase

Post-approval study

Sponsor

University of Missouri-Columbia

Collaborators

American Society for Metabolic and Bariatric Surgery

Enrollment target

~150 participants

Started

February 2024

Primary completion

July 2028

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov